September 22, 2025Journal of the American College of Cardiology
10 Issues for the Clinician in Tricuspid Regurgitation Evaluation and Management: 2025 ACC Expert Consensus Decision Pathway
No abstract yet
We only have this paper's title and publication details.
Read it at the sourceAsk about this paper
Answers are grounded in this paper and cite their sources.
Key expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The first message is it's very important to have an accurate diagnosis of tricuspid regurgitation. Understanding the mechanism, understanding the severity, and then understanding all the associated aspects, such as the extent of involvement of the right ventricle, liver, and kidney.”
“The writing committee “acknowledges how multidisciplinary the management of TR needs to be.” He pointed out that this decision pathway is not meant to be used as a fuller practice guideline, but as “more of a supportive document for physicians about how one might disentangle all the various complexities in this field.””
DPDr. Patrick T. O'GaraWriting Committee chair
“The availability of transcatheter interventions to treat severe TR has energized the cardiovascular community to improve evaluation and management strategies targeted at this valve lesion. This ECDP is intended to enable the clinician to assimilate the most important developments in this dynamically evolving field to improve the care of patients with severe TR... and is focused on the most common clinical areas encountered in practice from evaluation to treatment.”
Coverage & sources
Journal, society, and media accounts. Useful signal, not independent expert judgment.
Discussion
No takes yet. Share an insight, caveat, or question.
Cite This Study
O’Gara et al. (2025) studied this question.